Literature DB >> 14609823

Pseudoexfoliation in South India.

H Arvind1, P Raju, P G Paul, M Baskaran, S Ve Ramesh, R J George, C McCarty, L Vijaya.   

Abstract

AIM: To study the profile of pseudoexfoliation in a population based study.
METHOD: 2850 consecutive subjects aged 40 years or older from a population based survey in a rural area of southern India underwent complete ophthalmic evaluation including history, visual acuity testing, refraction, slit lamp examination, applanation tonometry, gonioscopy, and dilated examination of the lens (including LOCS II grading of cataract), fundus, and optic disc. Patients with pseudoexfoliation syndrome were identified and their data were analysed with respect to age, sex, intraocular pressure, gonioscopic grading, cataract, and optic neuropathy.
RESULTS: 108 subjects had pseudoexfoliation syndrome (3.8 %). There was a significant increase in prevalence with age but no sex predilection. The condition was unilateral in 53 cases (49.1%) and bilateral in 55 cases (50.9%). 18 cases with pseudoexfoliation (16.7%) had high intraocular pressure (>21 mm Hg), 16 cases (14.8%) had occludable angles, and 14 cases (13%) had pseudoexfoliation glaucoma. There was a significantly higher prevalence of cataract among people with pseudoexfoliation compared to those without pseudoexfoliation (p = 0.014).
CONCLUSION: The prevalence of pseudoexfoliation syndrome in the rural population of south India was 3.8%. Raised intraocular pressure was seen in 16.7% of people with pseudoexfoliation and glaucoma was present in 13%.

Entities:  

Mesh:

Year:  2003        PMID: 14609823      PMCID: PMC1771878          DOI: 10.1136/bjo.87.11.1321

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank.

Authors:  R Ritch; U Schlötzer-Schrehardt
Journal:  Acta Ophthalmol Scand       Date:  2001-04

2.  Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos, and Russians.

Authors:  H Forsius
Journal:  Trans Ophthalmol Soc U K       Date:  1979-07

3.  Exfoliation syndrome.

Authors:  W E Layden; R N Shaffer
Journal:  Am J Ophthalmol       Date:  1974-11       Impact factor: 5.258

4.  Anterior chamber angle in the exfoliation syndrome.

Authors:  P K Wishart; G L Spaeth; E M Poryzees
Journal:  Br J Ophthalmol       Date:  1985-02       Impact factor: 4.638

5.  Pseudo-exfoliation of the lens among the Navajo Indians.

Authors:  H W Faulkner
Journal:  Am J Ophthalmol       Date:  1971-07-30       Impact factor: 5.258

6.  Exfoliation syndrome. Prevalence in a southeastern United States population.

Authors:  L F Cashwell; M B Shields
Journal:  Arch Ophthalmol       Date:  1988-03

7.  Pseudoexfoliation syndrome (prevalence based on random survey hospital data).

Authors:  P A Lamba; A Giridhar
Journal:  Indian J Ophthalmol       Date:  1984 May-Jun       Impact factor: 1.848

8.  Pseudoexfoliation syndrome in Australian adults.

Authors:  C A Mccarty; H R Taylor
Journal:  Am J Ophthalmol       Date:  2000-05       Impact factor: 5.258

9.  Prevalence of primary glaucoma in an urban south Indian population.

Authors:  A Jacob; R Thomas; S P Koshi; A Braganza; J Muliyil
Journal:  Indian J Ophthalmol       Date:  1998-06       Impact factor: 1.848

10.  Intraocular pressure status in 100 consecutive patients with exfoliation syndrome.

Authors:  D M Kozart; M Yanoff
Journal:  Ophthalmology       Date:  1982-03       Impact factor: 12.079

View more
  26 in total

1.  The prevalence of pseudoexfoliation syndrome in Chinese people: the Tanjong Pagar Survey.

Authors:  P J Foster; S K L Seah
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

2.  Conjunctival changes in different clinical variants of early pseudoexfoliation.

Authors:  Aparna Rao; Gopinath Das; Sarada Sarangi; Debananda Padhy
Journal:  Int Ophthalmol       Date:  2017-10-30       Impact factor: 2.031

3.  Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts.

Authors:  Jae Hee Kang; Stephanie Loomis; Janey L Wiggs; Joshua D Stein; Louis R Pasquale
Journal:  Ophthalmology       Date:  2011-10-07       Impact factor: 12.079

4.  Glaucoma in aphakia and pseudophakia in the Chennai Glaucoma Study.

Authors:  H Arvind; R George; P Raju; S V Ramesh; M Baskaran; P G Paul; C McCarty; L Vijaya
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

5.  Geographic and climatic factors associated with exfoliation syndrome.

Authors:  Joshua D Stein; Louis R Pasquale; Nidhi Talwar; Denise S Kim; David M Reed; Bin Nan; Jae Hee Kang; Janey L Wiggs; Julia E Richards
Journal:  Arch Ophthalmol       Date:  2011-08

6.  MTHFR and MTHFD1 gene polymorphisms are not associated with pseudoexfoliation syndrome in South Indian population.

Authors:  Prakadeeswari Gopalakrishnan; Aravind Haripriya; Periasamy Sundaresan
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

7.  Prevalence of glaucoma types and legal blindness from glaucoma in the western region of Saudi Arabia: a hospital-based study.

Authors:  Tarek M Eid; Ihab el-Hawary; Wael el-Menawy
Journal:  Int Ophthalmol       Date:  2008-10-14       Impact factor: 2.031

8.  Analysis of Intraoperative and Postoperative Complications in Pseudoexfoliation Eyes Undergoing Cataract Surgery.

Authors:  B C Hemalatha; Sathyendranath B Shetty
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 9.  Importance of population-based studies in clinical practice.

Authors:  George Ronnie; Ramesh Sathyamangalam Ve; Lokapavani Velumuri; Rashima Asokan; Lingam Vijaya
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

10.  Complications and visual outcomes of cataract surgery in patients with pseudoexfoliation.

Authors:  Vivek M Singh; Revathy Yerramneni; Tanvi Madia; Sai Prashanthi; Pravin K Vaddavalli; Jagadesh C Reddy
Journal:  Int Ophthalmol       Date:  2021-06-15       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.